Compare KHC & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KHC | TEVA |
|---|---|---|
| Founded | 1869 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9B | 30.2B |
| IPO Year | N/A | N/A |
| Metric | KHC | TEVA |
|---|---|---|
| Price | $23.15 | $33.05 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 18 | 9 |
| Target Price | $26.89 | ★ $34.67 |
| AVG Volume (30 Days) | ★ 16.2M | 10.5M |
| Earning Date | 02-11-2026 | 01-28-2026 |
| Dividend Yield | ★ 6.91% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.21 |
| Revenue | ★ $25,164,000,000.00 | $17,258,000,000.00 |
| Revenue This Year | N/A | $0.63 |
| Revenue Next Year | N/A | $1.67 |
| P/E Ratio | ★ N/A | $27.33 |
| Revenue Growth | N/A | ★ 4.32 |
| 52 Week Low | $21.99 | $12.47 |
| 52 Week High | $33.35 | $33.44 |
| Indicator | KHC | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 42.85 | 69.86 |
| Support Level | $22.99 | $30.94 |
| Resistance Level | $23.91 | $32.86 |
| Average True Range (ATR) | 0.55 | 0.94 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 42.28 | 91.59 |
In July 2015, Kraft merged with Heinz to create one of North America's largest food and beverage manufacturers. However, the firm now intends to split its global sauces arm from its North American grocery segment in the second half of 2026. Beyond its namesake brands, its portfolio includes Oscar Mayer, Velveeta, and Philadelphia. While the retail channel drives around 85% of its total sales, the firm also maintains a growing foodservice presence. Outside North America, Kraft Heinz's global reach encompasses a distribution network in Europe and emerging markets, which accounts for nearly 25% of its consolidated sales base. The company's products are sold in more than 190 countries and territories.
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.